Research Article
BibTex RIS Cite

MEASURING THE KNOWLEDGE LEVEL OF LABORATORY WORKERS ABOUT HUMAN PAPILLOMAVIRUS AND VACCINES: A CROSS-SECTIONAL STUDY

Year 2025, Volume: 35 Issue: 3, 481 - 486, 30.06.2025
https://doi.org/10.54005/geneltip.1630392

Abstract

Aim: The aim of this study is to determine the knowledge level of laboratory workers about Human Papilloma Virus (HPV) and vaccines.
Material and Methods: Our study included doctors, technicians, biologists, doctoral and graduate students, and secretaries between the ages of 18-65 who actively work in biochemistry, microbiology, and pathology laboratories; 113 people accepted to fill out the survey. The HPV knowledge scale survey consists of a 22-question introductory characteristics form and a 33-question HPV knowledge level form. In our cross-sectional study, the HPV knowledge scale questionnaire consists of 5 main headings: sociodemographic data, general HPV knowledge level, knowledge status about HPV screening test, knowledge status about two types of HPV vaccines, and knowledge status about current HPV vaccines. The survey was administered via Google Forms after the necessary explanations were made.
Results: While the mean HPV knowledge score was found to be statistically significantly higher in women, those with a master's degree or higher, doctors, and those who stated that they had "enough knowledge" about HPV (p<0.05), the mean HPV knowledge score was found to be statistically significantly lower in those working in the biochemistry unit (p<0.05).
Conclusion: Healthcare workers, especially laboratory workers, should have sufficient knowledge about HPV, which can cause many pathologies including cervical cancer. Units and employees with deficiencies in their knowledge should be given the necessary training, and awareness about HPV and vaccines should be increased. Increasing health literacy is very important. By increasing the level of HPV knowledge, it is aimed to increase the level of knowledge not only of women but also of men. Information gaps regarding HPV transmission routes, vaccines and protection methods should be eliminated.

Ethical Statement

Ethics committee approval was obtained from the Necmettin Erbakan University Faculty of Medicine Non-Drug and Medical Device Research Board with the decision number 2024/5162.

Supporting Institution

-

Thanks

-

References

  • 1. World Health Organization (WHO). Human papillomavirus (HPV) and cervical cancer. Available from: https://www.who.int.
  • 2. De Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664-70.
  • 3. Demir Bozkurt F, Özdemir S. Validity and reliability of a Turkish version of the human papillomavirus knowledge scale: a methodological study. J Turk Ger Gynecol Assoc. 2023 Sep 7;24(3):177-186. doi: 10.4274/jtgga.galenos.2023.2022-10-9.
  • 4. Bruni L, Serrano B, Bosch FX, Castellsagué X, Brotons M, Muñoz J, et al. Cervical human papillomavirus prevalence in 5 continents: Meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2019;202(12):1789-99.
  • 5. Machalek DA, Poynten M, Jin J, Fairley CK, Farnsworth A, Garland SM, et al. Global burden of HPV-related diseases: Current perspectives. Vaccine. 2019;37(35):4670-80.
  • 6. Morales-Campos DY, Markham CM, Peskin MF, Fernandez ME, Byrd TL, Tortolero SR, et al. Cultural factors influencing HPV awareness and vaccine uptake in Latin America. Int J Gynecol Cancer. 2018;28(4):738-45.
  • 7. Cervical Screening Wales. HPV and laboratory staff: Knowledge and training needs. Internal Report;2018.
  • 8. Drolet M, Bénard É, Pérez N, Brisson M, Ali H, Boily MC, et al. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programs: Updated systematic review and meta-analysis. Lancet. 2019;394(10197):497-509.
  • 9. Garland SM, Giuliano AR, Brotherton JM, Palefsky JM, Ferenczy A, Ronco G, et al. HPV vaccination: A public health opportunity for males. Ther Adv. Vaccines. Immunothe 2020;8:2515135520906551.
  • 10. Chen L, Zhao Y, Cui J, Wang X, Xu Z, Zhang L, et al. Knowledge and attitudes about HPV vaccination among health professionals in the United States. Hum Vaccin Immunother. 2021;17(3):738-46.
  • 11. Stanley M. HPV vaccination in boys and men. Cancer Epidemiol Biomarkers Prev. 2012;21(4):667-74.
  • 12. Drolet M, Bénard É, Pérez N, Brisson M, Ali H, Boily MC, et al. The impact of HPV vaccination on the incidence of HPV-related cancers and the cost-effectiveness of vaccination in the general population. Vaccine. 2020;38(34):5319-26.
  • 13. Zimet GD, Rosberger Z, Fisher WA, Perez S, Stupiansky NW, Kahn JA, et al. Improving HPV vaccination rates among adolescents in the United States. Pediatrics. 2021;148(6):e2021053732.
  • 14. Hansen BT, Campbell S, Nygård M, Kristiansen IS, Støer NC, Tveit KS, et al. HPV-related knowledge and attitudes in the general population: A cross-sectional study in Denmark. BMC Public Health 2020;20(1):1405.
  • 15. Fernandez ME, Allen JD, Mistry R, Kharfen M, Morales-Campos D, Byrd TL, et al. HPV vaccination uptake among US adolescents: A systematic review and meta-analysis. Prev Med. 2022;154:106883.
  • 16. Lindsey AC, Kim S, Wilson KL, Pierce JY, Green CL, Brown RS, et al. Health professionals’ knowledge, attitudes, and practices towards HPV vaccination. Vaccine. 2021;39(17):2415-23.
  • 17. Smith PJ, Singleton JA, Zhao Z, Watson B, Ekong J, Orenstein WA, et al. Impact of health care provider recommendations on HPV vaccination initiation and completion. J Adolesc Health. 2020;66(3):337-44.
  • 18. Wang X, Zhang H, Zhao Y, Li Y, Wu J, Chen X, et al. HPV-related knowledge, attitudes, and vaccination intention among Chinese medical and nursing students. BMC Infect Dis. 2021;21(1):132.
  • 19. Petrosky E, Bocchini JA Jr, Hariri S, Chesson H, Curtis CR, Saraiya M, et al. Use of 9-valent human papillomavirus (HPV) vaccine: Updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2021;64(11):300-4.
  • 20. Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjosé S, Bruni L, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 2013;31:H1-H31.

LABORATUVAR ÇALIŞANLARININ HUMAN PAPİLLOMAVİRUS VE AŞILARI HAKKINDAKİ BİLGİ DÜZEYLERİNİN ÖLÇÜLMESİ: KESİTSEL BİR ÇALIŞMA

Year 2025, Volume: 35 Issue: 3, 481 - 486, 30.06.2025
https://doi.org/10.54005/geneltip.1630392

Abstract

Amaç: Literatürde çeşitli laboratuvarlarda çalışan sağlık profesyonellerinin Human Papilloma Virus (HPV) hakkındaki bilgi düzeylerinin araştırıldığı çalışmalar kısıtlıdır. Bu çalışmanın amacı laboratuvar çalışanlarının HPV ve aşıları hakkındaki bilgi düzeylerini tespit etmektir.
Gereç ve Yöntem: Çalışmamıza biyokimya, mikrobiyoloji ve patoloji laboratuvarlarında aktif olarak çalışan 18-65 yaş aralığındaki doktor, teknisyen, biyolog, doktora ve yüksek lisans öğrencileri, sekreterler dahil edilmiş olup; 113 kişi anket doldurmayı kabul etmiştir. HPV bilgi ölçeği anketi, 22 sorudan oluşan tanıtıcı özellikler formu ve 33 sorudan oluşan HPV bilgi düzeyini içeren formlardan oluşmaktadır. Kesitsel bir araştırma olan çalışmamızda HPV bilgi ölçeği anketi; sosyodemografik özellikler, HPV genel bilgi düzeyi, HPV tarama testi hakkındaki bilgi durumu, iki tip HPV aşısı hakkındaki bilgi düzeyi ve mevcut HPV aşıları hakkındaki bilgi durumu olmak üzere 5 ana başlıktan oluşmaktadır. Anketin uygulanması gerekli açıklamalar yapıldıktan sonra Google Forms üzerinden yapılmıştır.
Bulgular: HPV bilgi puan ortalamaları kadınlarda, yüksek lisans ve üzerinde eğitim alanlarda, doktorlarda ve HPV bilgi düzeyini “yeterince bilgim var” diyen gruplarda istatiksel olarak anlamlı derecede yüksek bulunmasına karşın (p<0,05), biyokimya biriminde çalışanlarda HPV bilgi puan ortalamaları istatiksel olarak anlamlı derecede düşük bulunmuştur (p<0,05).
Sonuç: Sağlık çalışanlarının özellikle de laboratuvar çalışanlarının serviks kanseri dahil olmak üzere birçok patolojiye sebep olabilen HPV hakkındaki bilgi düzeyleri yeterli olmalıdır. Bilgi düzeylerinde eksiklik saptanan birim ve çalışanlara gerekli eğitimler verilmeli, HPV ve aşıları hakkında farkındalık arttırılmaya çalışılmalıdır. Sağlık okuryazarlılığının arttırılması oldukça önemlidir. HPV bilgi düzeyi artırılarak, sadece kadınların değil erkeklerin de bilgi düzeyinin arttırılması amaçlanmalı; HPV bulaş yolları, aşıları ve korunma yöntemleriyle ilgili bilgi eksiklikleri giderilmelidir.

Ethical Statement

Necmettin Erbakan Üniversitesi Tıp Fakültesi İlaç ve Tıbbi Cihaz Dışı Araştırmalar Kurulu tarafından 2024/5162 sayılı kararla etik kurulu onayı alınmıştır.

Supporting Institution

-

Thanks

-

References

  • 1. World Health Organization (WHO). Human papillomavirus (HPV) and cervical cancer. Available from: https://www.who.int.
  • 2. De Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664-70.
  • 3. Demir Bozkurt F, Özdemir S. Validity and reliability of a Turkish version of the human papillomavirus knowledge scale: a methodological study. J Turk Ger Gynecol Assoc. 2023 Sep 7;24(3):177-186. doi: 10.4274/jtgga.galenos.2023.2022-10-9.
  • 4. Bruni L, Serrano B, Bosch FX, Castellsagué X, Brotons M, Muñoz J, et al. Cervical human papillomavirus prevalence in 5 continents: Meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2019;202(12):1789-99.
  • 5. Machalek DA, Poynten M, Jin J, Fairley CK, Farnsworth A, Garland SM, et al. Global burden of HPV-related diseases: Current perspectives. Vaccine. 2019;37(35):4670-80.
  • 6. Morales-Campos DY, Markham CM, Peskin MF, Fernandez ME, Byrd TL, Tortolero SR, et al. Cultural factors influencing HPV awareness and vaccine uptake in Latin America. Int J Gynecol Cancer. 2018;28(4):738-45.
  • 7. Cervical Screening Wales. HPV and laboratory staff: Knowledge and training needs. Internal Report;2018.
  • 8. Drolet M, Bénard É, Pérez N, Brisson M, Ali H, Boily MC, et al. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programs: Updated systematic review and meta-analysis. Lancet. 2019;394(10197):497-509.
  • 9. Garland SM, Giuliano AR, Brotherton JM, Palefsky JM, Ferenczy A, Ronco G, et al. HPV vaccination: A public health opportunity for males. Ther Adv. Vaccines. Immunothe 2020;8:2515135520906551.
  • 10. Chen L, Zhao Y, Cui J, Wang X, Xu Z, Zhang L, et al. Knowledge and attitudes about HPV vaccination among health professionals in the United States. Hum Vaccin Immunother. 2021;17(3):738-46.
  • 11. Stanley M. HPV vaccination in boys and men. Cancer Epidemiol Biomarkers Prev. 2012;21(4):667-74.
  • 12. Drolet M, Bénard É, Pérez N, Brisson M, Ali H, Boily MC, et al. The impact of HPV vaccination on the incidence of HPV-related cancers and the cost-effectiveness of vaccination in the general population. Vaccine. 2020;38(34):5319-26.
  • 13. Zimet GD, Rosberger Z, Fisher WA, Perez S, Stupiansky NW, Kahn JA, et al. Improving HPV vaccination rates among adolescents in the United States. Pediatrics. 2021;148(6):e2021053732.
  • 14. Hansen BT, Campbell S, Nygård M, Kristiansen IS, Støer NC, Tveit KS, et al. HPV-related knowledge and attitudes in the general population: A cross-sectional study in Denmark. BMC Public Health 2020;20(1):1405.
  • 15. Fernandez ME, Allen JD, Mistry R, Kharfen M, Morales-Campos D, Byrd TL, et al. HPV vaccination uptake among US adolescents: A systematic review and meta-analysis. Prev Med. 2022;154:106883.
  • 16. Lindsey AC, Kim S, Wilson KL, Pierce JY, Green CL, Brown RS, et al. Health professionals’ knowledge, attitudes, and practices towards HPV vaccination. Vaccine. 2021;39(17):2415-23.
  • 17. Smith PJ, Singleton JA, Zhao Z, Watson B, Ekong J, Orenstein WA, et al. Impact of health care provider recommendations on HPV vaccination initiation and completion. J Adolesc Health. 2020;66(3):337-44.
  • 18. Wang X, Zhang H, Zhao Y, Li Y, Wu J, Chen X, et al. HPV-related knowledge, attitudes, and vaccination intention among Chinese medical and nursing students. BMC Infect Dis. 2021;21(1):132.
  • 19. Petrosky E, Bocchini JA Jr, Hariri S, Chesson H, Curtis CR, Saraiya M, et al. Use of 9-valent human papillomavirus (HPV) vaccine: Updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2021;64(11):300-4.
  • 20. Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjosé S, Bruni L, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 2013;31:H1-H31.
There are 20 citations in total.

Details

Primary Language English
Subjects Clinical Sciences (Other)
Journal Section Original Article
Authors

Burak Ezer 0000-0003-1217-2080

Tunahan Uygun 0000-0003-3560-2514

Selin Uğraklı 0000-0001-7210-8377

Publication Date June 30, 2025
Submission Date January 31, 2025
Acceptance Date April 15, 2025
Published in Issue Year 2025 Volume: 35 Issue: 3

Cite

Vancouver Ezer B, Uygun T, Uğraklı S. MEASURING THE KNOWLEDGE LEVEL OF LABORATORY WORKERS ABOUT HUMAN PAPILLOMAVIRUS AND VACCINES: A CROSS-SECTIONAL STUDY. Genel Tıp Derg. 2025;35(3):481-6.

The Journal of General Medicine is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY NC).